Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 23:16:1869-1883.
doi: 10.2147/DMSO.S407480. eCollection 2023.

Haematological Parameters in People with Atherosclerotic Cardiovascular Disease versus Those Who are Only at Risk for Cardiovascular Disease: A Comparative Cross-Sectional Study

Ebsitu Abate  1 , Maria Degef  1 , Addisu Melkie  2 , Natesan Gnanasekeran  1 , Mohammed Mehdi  1 , Yosef Tolcha  3 , Dawit Chala  3
Affiliations

Haematological Parameters in People with Atherosclerotic Cardiovascular Disease versus Those Who are Only at Risk for Cardiovascular Disease: A Comparative Cross-Sectional Study

Ebsitu Abate et al. Diabetes Metab Syndr Obes. .

Abstract

Introduction: Cardiovascular disease (CVD) is the foremost killer disease worldwide. ASCVD is one of the most common types of CVD. It is mainly associated with a condition called atherosclerosis. Its occurrence is linked to several risk factors. Hypertension, diabetes, dyslipidemia, smoking, genetic factors, and so on are examples. The presence of ASCVD, as well as its risk factors, causes a variety of disruptions in the body's physiological and biological functions. The presence of abnormal physiological and biological functions, for example, tends to disrupt hematological parameters.

Purpose: The study's aim was to assess and compare the pattern of hematological parameters in people with established atherosclerotic cardiovascular disease (ASVD) versus people with ASCVD risks alone who attended TASH Addis Ababa, Ethiopia, as well as to correlate hematological parameters with the novel inflammatory marker hs-CRP.

Methods: A prospective cross-sectional comparative study with 100 study participants was conducted during where October 2019-March 2020 proposal development, sample collection, and lab analysis period, and from March 2020-June to 2021 data entry, analysis, and writing period. A serum sample was collected from each study participant for the lipid and hsCRP analyses and whole blood for hematological parameter determination. The socio-demographic characteristics of the study participants were obtained through a well-structured questionnaire.

Results: The ASCVD-risk group had significantly higher mean platelet volume (MPV), which was associated with the presence of the risk. Furthermore, hs-CRPs show a significant correlation with MPV in a correlation analysis of highly sensitive C-reactive protein (hs-CRP) with hematological parameters. Thus, using these affordable, routinely tested, and easily available tests may help to infer future ASCVD risk as well as the presence of ASCVD morbidity while hsCRP level in comparison group vs cases requires further study.

Keywords: ASCVD; diabetes; hematological parameters; hs-CRP; hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors report that they do not have any competing interests.

Figures

Figure 1
Figure 1
Classification of the comparison group according to the Framingham risk score.
Figure 2
Figure 2
Comparison of hs-CRP (N=100).
Figure 3
Figure 3
Correlation of hs-CRP and MPV. In the case group, p=0.016, r =0.341, derived from the Pearson correlation test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kaptoge S, Pennells L, De Bacquer D, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332–e45. doi:10.1016/S2214-109X(19)30318-3 - DOI - PMC - PubMed
    1. Barquera S, Pedroza-Tobías A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328–338. doi:10.1016/j.arcmed.2015.06.006 - DOI - PubMed
    1. Maisch B, Oelze R. Cardiovascular Benefits of Omega-3 Polyunsaturated Fatty Acids. IOS Press; 2006.
    1. Ninomiya J, Criqui MH, Whyte JL, Gamst A, Chen RS, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation. 2004;109:42–46. doi:10.1161/01.CIR.0000108926.04022.0C - DOI - PubMed
    1. Cornier M-A, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777–822. doi:10.1210/er.2008-0024 - DOI - PMC - PubMed